4 June 2021 · The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.
26 April 2021 · Patient Group Directions are not an appropriate mechanism for regular repeated supplies or administration of a medicine. Prescribing is preferred.
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
9 September 2020 · Advice on the legal labelling requirements for Prescription Only Medicines and Pharmacy Medicines supplied under a patient group direction or legal exemption.
4 August 2020 · The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…
11 February 2020 · Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.